StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the medical research company’s stock.
Check-Cap Stock Performance
Check-Cap stock opened at $1.27 on Thursday. Check-Cap has a 52 week low of $1.12 and a 52 week high of $3.94. The stock has a market capitalization of $7.43 million, a P/E ratio of -0.42 and a beta of 0.36. The stock has a fifty day moving average of $1.65 and a 200-day moving average of $1.97.
Check-Cap Company Profile
Further Reading
- Five stocks we like better than Check-Cap
- What is a Low P/E Ratio and What Does it Tell Investors?
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- The Basics of Support and Resistance
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- What is the Nasdaq? Complete Overview with History
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.